University of Chicago BREATHE Laboratory
Chicago, Illinois, 60637, United States
Location status: Recruiting
NCT Number: NCT06395415
Electronic Nicotine Delivery Systems (ENDS) use remains prevalent among young adults, and many have high interest in quitting, yet research on effective intervention is lacking. A mobile health (mHealth) intervention that translates effective smoking cessation materials and pharmacotherapy may be a promising avenue for intervention. The initial phase of the proposed study uses a pilot study to evaluate a novel mHealth intervention for young adult ENDS and dual product (ENDS and combustible cigarette) users.
Interested in participating?
Request Info18 year–26 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60637, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention is delivered directly to participants' mobile phones using the Insight® platform, which allows for the implementation of assessments and interventions. Insight has been used in prior mHealth studies and allows for the delivery of tailored content based on parameters, such as intervention stage. The intervention has two stages: 1) Motivational enhancement (weeks 1-2) and 2) Skills and information (weeks 3-6). The first stage of messages will utilize personalized feedback and motivational interviewing prompts, while the second stage will provide health information on ENDS and skills, such as deep breathing. Content is tailored to motivation level (low/medium or high) and dual use status.
Those in the standard advice group will be given offered a sample of NRT, instruction on its use, and will be encouraged to use in conjunction with standard web-based resources on ENDS and cessation over the course of a ten minute walk-through with study staff.
Time frame: post-treatment (6 weeks) and at 6-week follow-up (week 12).
ENDS cessation will be measured using a modified Timeline Followback Interview using 7-day point prevalence abstinence with study staff and then confirmed via a mailed saliva cotinine test.
Time frame: post-treatment (6 weeks) and at 6-week follow-up (week 12).
Frequency of ENDS use as determined by Timeline Followback Interview with study staff will be measured as a secondary outcome.
Contact information is provided by the study sponsor or research team.
University of Chicago
Other
Acronym: EQUIP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06919263
Behavior, Electronic Nicotine Delivery Systems
Los Angeles, California, United States
View Trial DetailsNCT05962411
Behavior, Electronic Nicotine Delivery Systems
Beijing, Beijing Municipality, China
View Trial DetailsNCT06372899
Behavior, Cigarette Smoking
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06264154
Behavior, Cigarette Smoking
Philadelphia, Pennsylvania, United States
View Trial Details